| 标题 |
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Jeffrey S. Heier; Arshad M. Khanani; Carlos Quezada-Ruiz; Karen Basu; Philip J. Ferrone; et al 出版日期:2022-01-24 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)